Evidence map›Paper›PMID 24757287›Full record

ArticleMediators of inflammation2014

TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice.

Viktoriya Milanova, Nina Ivanovska, Petya Dimitrova

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Upregulation of osteoprotegerin inhibitsExperimental and therapeutic medicine · 2022
    Article
  4. Article
  5. Article
  6. IL-17 PromotesJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  7. Interleukin-17A Deficiency Attenuated Emphysema and Bone Loss in Mice Exposed to Cigarette Smoke.International journal of chronic obstructive pulmonary disease · 2020
    Article
  8. Review
  9. Review
  10. The Role of Osteoprotegerin and Its Ligands in Vascular Function.International journal of molecular sciences · 2019
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Viktoriya MilanovaDepartment of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev street, 1113 Sofia, Bulgaria.
Nina IvanovskaDepartment of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev street, 1113 Sofia, Bulgaria.
Petya DimitrovaDepartment of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev street, 1113 Sofia, Bulgaria.ORCID 0000-0003-0920-3712
Bulgarian Academy of Sciences · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the ability of neutrophils to express receptor activator of nuclear factor kappa-B ligand (RANKL), to secrete osteoprotegerin (OPG), and to produce IL-17. Arthritis was induced by intra-articular injection of zymosan, a ligand for Toll-like receptor 2 (TLR2). Frequencies of neutrophils in bone marrow (BM), blood and synovial fluid (SF), receptor expression, and cytokine production were evaluated by flow cytometry. 1A8 antibody (1A8 Ab) was used to deplete neutrophils in zymosan-injected SCID mice. IL-17, RANKL, and OPG amounts in SF, serum, or cell cultures were determined by ELISA. The development of arthritis was associated with increased secretion of IL-17, RANKL, and OPG in serum and SF, elevated frequencies of Ly6G(+)CD11b(+) cells in BM, blood, and SF and upregulated RANKL expression. Both IL-17 and OPG were absent in serum and SF after neutrophil depletion; therefore we assume that they were released by neutrophils. In vitro blood Ly6G(+)CD11b(+) cells from arthritic mice produced spontaneously IL-17, IFN-γ, and OPG and expressed RANKL. This phenotype was sustained by IL-17. TLR2 engagement increased IL-17 and IFN-γ production, potentiated IL-17-mediated RANKL expression, and inhibited OPG secretion. We conclude that TLR2 regulates the destructive potential of neutrophils and its targeting might limit joint alterations in arthritis.

Indexed as

AnimalsArthritisCytokinesDisease Models, AnimalGene Expression RegulationInterferon-gammaInterleukin-17MiceMice, Inbred BALB CMice, SCIDNeutrophilsOsteoprotegerinPhenotypeRANK LigandSynovial FluidSynovial MembraneCytokinesIl17a protein, mouseInterferon-gammaInterleukin-17OsteoprotegerinRANK LigandTlr2 protein, mouseTnfrsf11b protein, mouseTnfsf11 protein, mouseToll-Like Receptor 2

Identifiers

PMID24757287
PMCPMC3976781
OpenAlexW2071850452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.